SPAC Right
A unit component that converts into a fraction of a share when a deal closes, and into nothing if it does not.
A SPAC right entitles the holder to receive a fraction of a Class A share — one-tenth is the most common convention — automatically on the completion of a business combination, with no exercise price and no action required. It is not an option and cannot be exercised early. If the SPAC liquidates without a deal, the right expires worthless and receives no trust distribution.
In detail
Rights are the smaller-deal alternative to warrants. Where a sponsor cannot sell a unit on a warrant fraction alone, or where the underwriter's structure favors it, the unit includes a right: a contractual entitlement to 1/10, 1/8, or some other fraction of a share, delivered at the closing of the initial business combination. Rights appear disproportionately in smaller offerings and are more common on some listing venues than others.
Rights come to exist in the IPO as a unit component, registered on the S-1, with the rights agreement filed as an exhibit. They separate from the unit on the same schedule as the other components and trade under a suffixed ticker.
A holder owns a contingent contractual entitlement. There is no exercise price, no vote, no dividend, and no redemption right against the trust. The two facts that define the instrument are that conversion is automatic on closing, and that no closing means no conversion and no residual claim. A right is therefore a pure bet on deal completion, priced as the fraction of the expected post-close share value discounted by the probability of a deal and the time to it.
Fractional-share mechanics matter more than they appear to. Rights agreements typically provide that no fractional shares will be issued on conversion; depending on the agreement, fractions may be rounded down — meaning a holder of fewer than the conversion denominator receives nothing — rounded up, or aggregated at the beneficial-holder level. Some agreements require holders to surrender certificates or tender through the depository to receive the shares, and a few provide a cash alternative in stated circumstances. Those provisions are in the agreement and are regularly missed.
Lifecycle events: rights agreement as an exhibit to the IPO filings; separation from the unit; treatment in the business combination, disclosed in the S-4 or proxy; automatic conversion at closing, reflected in the closing 8-K's share count; amendment or exchange of rights as part of deal negotiation, disclosed in 8-K; worthless expiry on liquidation, disclosed in the liquidation 8-K.
Before assuming anything, find the conversion fraction and the fractional-share treatment; confirm the SPAC's deadline and whether an extension is pending; and price the instrument against completion probability rather than against the share, because a right that never converts is not a discounted share — it is nothing.
<!-- END PART 1 — 20/20 items merged. Discard log: O long fields superseded in all 20 (retained as fact-donors, deltas folded); O one-liners superseded 20/20; O shorts superseded 18/20, blended 2/20 (SEC-01, SEC-03). No inter-pack factual conflicts requiring primary-source resolution in this family — divergences were coverage differences, not contradictions. Zero [VERIFY] marks present in either pack's SEC-* family. -->
These values are read from the filing linked above. They describe the instrument, not its merits. Nothing here is investment advice.